Progress in Disease Modeling for Myocardial Infarction and Coronary Artery Disease: Bridging In Vivo and In Vitro Approaches DOI Creative Commons

Riya Kar,

Debabrata Mukhopadhyay, Ramcharan Singh Angom

и другие.

Hearts, Год журнала: 2024, Номер 5(4), С. 429 - 447

Опубликована: Окт. 4, 2024

Recent advancements in disease modeling for myocardial infarction (MI) and coronary artery (CAD) have significantly enhanced our understanding of cardiovascular pathology therapeutic development. This review comprehensively reviews the integration vivo vitro approaches to better model study these conditions. We specifically focus on cutting-edge techniques, such as cardiac organoids, engineered heart tissues, patient-derived induced pluripotent stem cells (iPSCs), which allow detailed exploration cellular molecular mechanisms involved MI CAD. These models provide insights into ischemic injury, remodeling, effects potential interventions at a level. In parallel, we discuss advances models, including genetically modified mice large animal offer valuable information progression, function, response treatments within more complex physiological context. By bridging approaches, researchers can gain comprehensive mechanisms, validate experimental findings, accelerate development effective therapies. highlights recent progress, identifies current limitations, proposes strategies future research enhance translation model-based discoveries clinical practice

Язык: Английский

Unveiling the Heart’s Hidden Enemy: Dynamic Insights into Polystyrene Nanoplastic-Induced Cardiotoxicity Based on Cardiac Organoid-on-a-Chip DOI

Tianyi Zhang,

Sheng Yang, Yiling Ge

и другие.

ACS Nano, Год журнала: 2024, Номер 18(45), С. 31569 - 31585

Опубликована: Ноя. 1, 2024

Exposure to micro- and nanoplastics (MNPs) has been implicated in potential cardiotoxicity. However, vitro models based on cardiomyocyte cell lines lack crucial cardiac characteristics, while interspecies differences animal compromise the reliability of conclusions. In addition, current research predominantly focused single-time point exposures MNPs, neglecting comparative analyses injury across early late stages. Moreover, there remains a large gap understanding susceptibility MNPs under pathological conditions. To address these limitations, this study integrated organoids (COs) organ-on-a-chip (OoC) technology develop organoid-on-a-chip (COoC), which was validated for cardiotoxicity evaluation through multiple dimensions. Based COoC, we conducted dynamic observation damage caused by short- long-term exposure polystyrene (PS-NPs). Oxidative stress, inflammation, disruption calcium ion homeostasis, mitochondrial dysfunction were confirmed as mechanisms PS-NP-induced events stages, fibrosis emerged prominent feature Notably, low-dose exacerbated myocardial infarction symptoms states, despite no significant shown healthy models. conclusion, findings further deepened our cardiotoxic effects introduced promising platform assessing

Язык: Английский

Процитировано

4

Use of Brain Death Recipients in Xenotransplantation: A Double‐Edged Sword DOI

Xingchao Du,

Yuan Chang, Jiangping Song

и другие.

Xenotransplantation, Год журнала: 2025, Номер 32(1)

Опубликована: Янв. 1, 2025

Organ transplants are used to treat many end-stage diseases, but a shortage of donors means patients cannot be treated. Xenogeneic organs have become an important part filling the donor gap. Many current studies kidney, heart, and liver xenotransplantation gene-edited pig on brain-dead recipients. However, endocrine system, immune nervous system people changed, which different from that real transplanted, research results brain death (BD) recipients also different. So there drawbacks using for xenotransplantation. In addition, although policy requires use non-human primate (NHP) experiments as standard xenotransplantation, still differences between NHP humans in terms immunity. Therefore, better study new models may needed addition individuals. Humanized animal or organoids able fill this

Язык: Английский

Процитировано

0

Advances in cardiac organoid research: implications for cardiovascular disease treatment DOI Creative Commons

Ziteng Huang,

Keran Jia,

Yadan Tan

и другие.

Cardiovascular Diabetology, Год журнала: 2025, Номер 24(1)

Опубликована: Янв. 18, 2025

Globally, cardiovascular diseases remain among the leading causes of mortality, highlighting urgent need for innovative research models. Consequently, development accurate models that simulate cardiac function holds significant scientific and clinical value both disease therapeutic interventions. Cardiac organoids, which are three-dimensional structures derived from induced differentiation stem cells, particularly promising. These organoids not only replicate autonomous beating essential electrophysiological properties heart but also widely employed in studies related to diseases, drug efficacy testing, regenerative medicine. This review comprehensively surveys various fabrication techniques used create their diverse applications modeling a range diseases. We emphasize role advanced technologies enhancing maturation functionality ensuring these closely resemble native tissue. Furthermore, we discuss monitoring evaluation parameters critical assessing performance considering complex interactions within multi-organ systems. approach is vital precision efficiency development, allowing more effective strategies. Ultimately, this aims provide thorough perspective on fundamental treatment offering insights could pave way future advancements understanding addressing prevalent health challenges.

Язык: Английский

Процитировано

0

Probiotics and Prebiotics: Meeting Dietary Requirements for Optimal Health and Planetary Sustainability DOI
Juan Chen, Yifei Yu,

Siyuan Sun

и другие.

Journal of Nutrition, Год журнала: 2025, Номер unknown

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Advances in humanoid organoid-based research on inter-organ communications during cardiac organogenesis and cardiovascular diseases DOI Creative Commons

Baoqiang Ni,

Lingqun Ye, Yan Zhang

и другие.

Journal of Translational Medicine, Год журнала: 2025, Номер 23(1)

Опубликована: Март 28, 2025

The intimate correlation between cardiovascular diseases and other organ pathologies, such as metabolic kidney diseases, underscores the intricate interactions among these organs. Understanding inter-organ communications is crucial for developing more precise drugs effective treatments systemic diseases. While animal models have traditionally been pivotal in studying interactions, human-induced pluripotent stem cells (hiPSCs) offer distinct advantages when constructing vitro models. Beyond conventional two-dimensional co-culture model, hiPSC-derived humanoid organoids emerged a substantial advancement, capable of replicating essential structural functional attributes internal organs vitro. This breakthrough has spurred development multilineage organoids, assembloids, organoids-on-a-chip technologies, which allow enhanced physiological relevance. These technologies shown great potential mimicking coordinated organogenesis, exploring disease pathogenesis, facilitating drug discovery. As central system, heart serves focal point an extensively studied network interactions. review focuses on advancements challenges organs, presenting comprehensive exploration this cutting-edge approach research.

Язык: Английский

Процитировано

0

Progress in Disease Modeling for Myocardial Infarction and Coronary Artery Disease: Bridging In Vivo and In Vitro Approaches DOI Creative Commons

Riya Kar,

Debabrata Mukhopadhyay, Ramcharan Singh Angom

и другие.

Hearts, Год журнала: 2024, Номер 5(4), С. 429 - 447

Опубликована: Окт. 4, 2024

Recent advancements in disease modeling for myocardial infarction (MI) and coronary artery (CAD) have significantly enhanced our understanding of cardiovascular pathology therapeutic development. This review comprehensively reviews the integration vivo vitro approaches to better model study these conditions. We specifically focus on cutting-edge techniques, such as cardiac organoids, engineered heart tissues, patient-derived induced pluripotent stem cells (iPSCs), which allow detailed exploration cellular molecular mechanisms involved MI CAD. These models provide insights into ischemic injury, remodeling, effects potential interventions at a level. In parallel, we discuss advances models, including genetically modified mice large animal offer valuable information progression, function, response treatments within more complex physiological context. By bridging approaches, researchers can gain comprehensive mechanisms, validate experimental findings, accelerate development effective therapies. highlights recent progress, identifies current limitations, proposes strategies future research enhance translation model-based discoveries clinical practice

Язык: Английский

Процитировано

1